U.S. flag

An official website of the United States government

NM_000143.4(FH):c.698G>T (p.Arg233Leu) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 25, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001781272.13

Allele description [Variation Report for NM_000143.4(FH):c.698G>T (p.Arg233Leu)]

NM_000143.4(FH):c.698G>T (p.Arg233Leu)

Gene:
FH:fumarate hydratase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q43
Genomic location:
Preferred name:
NM_000143.4(FH):c.698G>T (p.Arg233Leu)
Other names:
R190L
HGVS:
  • NC_000001.11:g.241508643C>A
  • NG_012338.1:g.16112G>T
  • NM_000143.4:c.698G>TMANE SELECT
  • NP_000134.2:p.Arg233Leu
  • NP_000134.2:p.Arg233Leu
  • LRG_504t1:c.698G>T
  • LRG_504:g.16112G>T
  • LRG_504p1:p.Arg233Leu
  • NC_000001.10:g.241671943C>A
  • NM_000143.3:c.698G>T
  • p.[Arg233Leu]
Protein change:
R233L; ARG190LEU
Links:
OMIM: 136850.0008; dbSNP: rs121913123
NCBI 1000 Genomes Browser:
rs121913123
Molecular consequence:
  • NM_000143.4:c.698G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002219616Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 25, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV004025213Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 15, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC).

Bhola PT, Gilpin C, Smith A, Graham GE.

Fam Cancer. 2018 Oct;17(4):615-620. doi: 10.1007/s10689-018-0076-4.

PubMed [citation]
PMID:
29423582

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.

Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B.

Am J Hum Genet. 2003 Jul;73(1):95-106. Epub 2003 May 22.

PubMed [citation]
PMID:
12772087
PMCID:
PMC1180594
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002219616.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 233 of the FH protein (p.Arg233Leu). This variant is present in population databases (rs121913123, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of hereditary leiomyomatosis and renal cell cancer (PMID: 12772087, 29423582; Invitae). This variant is also known as c.569G>T, p.Arg190Leu. ClinVar contains an entry for this variant (Variation ID: 16237). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FH protein function. This variant disrupts the p.Arg233 amino acid residue in FH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12772087, 15937070, 21398687; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV004025213.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024